ASX Share rice
Sun 16 May 2021 - 06:47:am (Sydney)

HCT Share Price

HOLISTA COLLTECH LIMITEDHCTHousehold & Personal Products

HCT Company Information

Name:

Holista CollTech Limited

Sector:

Consumer Defensive

Industry:

Packaged Foods

GIC Industry:

Personal Products

GIC Sub Industry:

Personal Products

Address:

126 Phillip Street Sydney NSW Australia 2000

Phone:

61 2 8072 1400

CEO, MD & Non-independent Director:

Dr. Rajendran Manickavasagar

Non-Exec. Director & Company Sec.:

Mr. Blair James Michelson

Chief Financial Officer:

Mr. James Richard Stephenson C.M.A., M.A.I.C.D., M.B.A., CMA, P.Geo, FCIS, MBA

Chief Financial Officer:

Mee Ling Chin

Chief Operating Officer:

Mr. Bob Lee

Exec. Assistant to Chief Exec. Officer:

Ms. Yasmin Cheah

Company Overview:

Holista CollTech Limited operates as a biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection control Solutions, and Food Ingredients segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; and healthy food ingredients, including low-glycaemic index (GI) flour mix for noodles, pasta, flatbreads and other baked products, low-sodium salt, low-fat fried foods, less-calorie sugar, and low-GI sugar. It also provides infection control solutions. Holista CollTech Limited is headquartered in Sydney, Australia.

HCT Share Price Information

Shares Issued:

275.35M

Market Capitalisation:

$14.32M

Revenue (TTM):

$7.35M

Revenue Per Share (TTM):

$0.03

Earnings per Share:

$-0.005

Profit Margin:

-0.7464

Operating Margin (TTM):

$-0.59

Return On Assets (TTM):

$-0.34

Return On Equity (TTM):

$-1.38

Quarterly Revenue Growth (YOY):

0.17

Gross Profit(TTM):

$4.23M

Diluted Earnings Per Share (TTM):

$-0.02

HCT CashFlow Statement

CashFlow Date:

2020-12-31

Investments:

$-46,405

Change To Liabilities:

$-1,308,262

Total Cashflow From Investing Activities:

$-80,746

Net Borrowings:

$82.05K

Net Income:

$-5,483,167

Total Cash From Operating Activities:

$-3,867,610

Depreciation:

$220.87K

Other Cashflow From Investing Activities:

$-46,405

Change To Inventory:

$-481,738

Change To Account Receivables:

$-407,456

Sale Purchase Of Stock:

$-29,874

Capital Expenditures:

$13.36K

HCT Income Statement

Income Date:

2020-12-31

Income Before Tax:

$-5,589,241

Net Income:

$-5,440,426

Gross Profit:

$3.99M

Operating Income:

$-4,539,703

Other Operating Expenses:

$750.75K

Interest Expense:

$68.41K

Income Tax Expense:

$86.59K

Total Revenue:

$7.11M

Cost Of Revenue:

$3.12M

HCT Balance Sheet

Balance Sheet Date:

2020-12-31

Intangible Assets:

$106.28K

Total Liabilities:

$3.36M

Total Stockholder Equity:

$5.46M

Other Current Liabilities:

$0.98M

Total Assets:

$8.03M

Common Stock:

$21.71M

Other Current Assets:

$443.16K

Retained Earnings:

$-16,149,123

Other Liabilities:

$275K

Other Assets:

$75.41K

Cash:

$2.73M

Total Current Liabilities:

$2.62M

Short-Term Debt:

$717.22K

Property - Plant & Equipment:

$1.24M

Net Tangible Assets:

$5.27M

Total Current Assets:

$6.59M

Long-Term Debt:

$430.61K

Net Receivables:

$2.08M

Short-Term Investments:

$1.96M

Inventory:

$1.11M

Accounts Payable:

$829.86K

Non Currrent Assets (Other):

$481.64K

Short-Term Investments:

$1.96

Non Current Liabilities Total:

$788.37K

HCT Share Price History

HCT News